The recommendations will likely lead to a lower uptake of the new vaccines than the manufacturers might have expected had the ACIP voted to accept the stronger “should” recommendation. At a point this spring, a GSK executiveprojected that salesof the RSV vaccine could rival those of Shingrix,...
CDC: RSV Vaccine Recommended for Older PeopleCENTERS for Disease Control & Prevention (U.S.)RESPIRATORY syncytial virus infection vaccinesOLDER peopledoi:10.1001/jama.2023.12537Harris, EmilyJAMA: Journal of the American Medical Association
If you're young and healthy, the vaccine may not benefit you as much, but you still should consider getting it if you live with someone in one of these categories or want to reduce the risk of a COVID-19 infection. Overall, there is little to no harm in getting the vaccine for prot...
In short, the new guidelines encourage all adults ages 75 and older and individuals who are between 60 and 74 with an elevated risk of getting severe RSV to get the RSV vaccine. For adults between 60 and 74 years, an elevated risk of severe RSV may be a result of a...
Vaccine makers are still studying when seniors might need to come back for a booster dose of RSV vaccine in the coming years. They also have yet to decide on a final price, further complicating broader recommendations. GSK said their vaccine could be priced between $200 and $295 per dose,...
The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from respiratory syncytial virus. The CDC said the Pfizer vaccine should be taken during weeks 32 and 36 of pregnancy.Sept 23, 2023 ...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
The new CDC report focused on 28 cases of the syndrome in people who were vaccinated, and all but one developed symptoms within 21 days. That translated to 1.5 cases per million in people who got the GSK RSV vaccine, and five cases per million in recipients of the Pfizer shot. ...
"We have more tools than ever before and we have vaccines for all three major fall and winter respiratory viruses again. COVID, flu and for the first time we have an RSV vaccine for older adults and an RSV immunization for our infants," she said. ...
older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care provider about whether RSV vaccination is the best course of action for ...